AHK-Cu
Also known as: Copper Tripeptide AHK, Alanine-Histidine-Lysine Copper, AHK Copper Complex
A copper-binding tripeptide similar to GHK-Cu, specifically researched for hair follicle stimulation and scalp health. Shows promise for hair growth and preventing hair loss.
Half-Life
Short (hours)
Typical Dose
1-3 mg
Frequency
Once daily
Routes
Topical
Overview
AHK-Cu (Alanine-Histidine-Lysine:Copper) is a copper-binding tripeptide that has gained significant attention for its potential hair growth properties. While similar to the better-known GHK-Cu, AHK-Cu has a distinct amino acid sequence that may offer unique benefits for hair follicle health and scalp conditions.
The peptide consists of:
- Alanine (Ala/A): Supports protein structure
- Histidine (His/H): Critical for copper binding
- Lysine (Lys/K): Essential amino acid for tissue repair
- Copper (Cu2+): Cofactor for numerous enzymes
Key Characteristics
- Origin: Synthetic copper-binding tripeptide
- Classification: Copper peptide complex
- Molecular Weight: ~370 g/mol (without copper)
- Primary Focus: Hair growth and scalp health
- Safety Profile: Generally well-tolerated
AHK-Cu vs GHK-Cu
| Feature | AHK-Cu | GHK-Cu | |---------|--------|--------| | Sequence | Ala-His-Lys | Gly-His-Lys | | First Amino Acid | Alanine | Glycine | | Primary Research | Hair growth | Wound healing | | Copper Affinity | High | Very high | | Natural Occurrence | Less common | Found in human plasma | | Applications | Hair/scalp focus | Broader applications |
Mechanism
Primary Mechanisms
1. Hair Follicle Stimulation
AHK-Cu affects hair follicles through:
- Prolongation of the anagen (growth) phase
- Increase in hair follicle size
- Enhancement of dermal papilla cell proliferation
- Improved follicle vascularization
2. Copper Delivery to Scalp
As a copper complex:
- Delivers bioavailable copper to hair follicles
- Copper is essential for melanin production (hair color)
- Supports enzymatic processes in hair growth
- May help with premature graying
3. Extracellular Matrix Support
Effects on scalp tissue:
- Promotes collagen synthesis
- Supports glycosaminoglycan production
- Improves scalp tissue health
- Creates favorable environment for hair growth
4. DHT Modulation (Proposed)
Some research suggests:
- Potential interference with DHT at follicle level
- May reduce DHT-induced miniaturization
- Protective effects on hair follicle stem cells
- Needs more research to confirm
Cellular Effects
At the follicular level:
- Stimulates hair matrix keratinocytes
- Enhances dermal papilla signaling
- Supports stem cell niche
- Reduces follicle inflammation
Research
Research Note: While AHK-Cu shows promise for hair growth, much of the evidence comes from in vitro studies and limited clinical observations. More controlled human trials are needed.
Hair Growth Studies
In Vitro Research
Laboratory studies have demonstrated:
- Increased proliferation of dermal papilla cells
- Enhanced expression of hair growth factors
- Prolonged anagen phase in culture models
- Improved hair follicle morphology
Clinical Observations
Reported outcomes include:
- Increased hair density after 3-6 months
- Improved hair thickness
- Reduced hair shedding
- Enhanced scalp health
Scalp Health Applications
Seborrheic Dermatitis
- Potential anti-inflammatory effects on scalp
- May help regulate sebum production
- Supports scalp barrier function
Scalp Aging
- Addresses age-related follicle decline
- May slow follicle miniaturization
- Supports scalp collagen
Comparative Research
Studies comparing copper peptides suggest:
- AHK-Cu may have stronger hair-specific effects
- GHK-Cu broader regenerative profile
- Combination approaches may be synergistic
- Both improve scalp health markers
Dosing
Disclaimer: All dosing information is for research reference only. AHK-Cu is not approved for human use by the FDA. Consult a healthcare provider before considering any peptide use.
Research Protocols
| Protocol | Dose | Frequency | Duration |
|---|---|---|---|
| Topical (Serum/Cream) | 0.1-0.5% | 1-2x daily | 3-6 months |
| Mesotherapy (Scalp) | 1-2 mg per session | Weekly | 8-12 sessions |
| Subcutaneous (Scalp) | 1-2 mg | 3x weekly | 12-24 weeks |
| Microneedling + Topical | Apply after procedure | Weekly | 12 weeks |
Administration Methods
Topical Application
- Most common and safest method
- Apply to clean, dry scalp
- Massage gently to improve absorption
- Use at night for best absorption
- Can be combined with minoxidil (separate applications)
Mesotherapy
- Professional administration recommended
- Multiple microinjections across scalp
- Higher local concentration achieved
- May be combined with other hair growth factors
Microneedling Enhancement
- Microneedling improves peptide penetration
- Apply immediately after procedure
- Creates microchannels for absorption
- Enhanced efficacy reported
Formulation Considerations
Stability
- Copper peptides require proper formulation
- pH between 5.5-6.5 optimal
- Protect from oxidation
- Slight blue color indicates intact copper complex
Vehicles
- Serums (water or oil-based)
- Creams and lotions
- Liposomal formulations
- Professional mesotherapy solutions
Synergy & Stacking
Common Combinations for Hair
AHK-Cu + Minoxidil
Popular combination:
- Minoxidil: Vasodilation, increased blood flow
- AHK-Cu: Follicle stimulation, copper delivery
- Apply at different times (morning/night)
- May enhance each other's effects
AHK-Cu + GHK-Cu
Dual copper peptide approach:
- AHK-Cu: Hair-specific effects
- GHK-Cu: Broader tissue support
- Can be used together topically
- Comprehensive copper delivery
AHK-Cu + Hair Growth Factors
Enhanced protocols may include:
- Biotin supplementation
- Keratin growth factor
- Thymosin Beta-4 fragments
- PRP (platelet-rich plasma)
Timing Considerations
- Apply on clean scalp
- Allow absorption before other products
- Night application may be optimal
- Consistent daily use important
Safety
Known Side Effects
Topical Use (Common)
- Mild scalp irritation (usually temporary)
- Slight staining of fingers (copper color)
- Initial shedding (may occur before improvement)
Injectable/Mesotherapy
- Injection site reactions
- Temporary scalp redness
- Rare: local infection (maintain sterility)
Contraindications
Avoid if:
- Copper sensitivity or allergy
- Wilson's disease (copper metabolism disorder)
- Open wounds on scalp
- Active scalp infections
Use with caution if:
- Sensitive scalp conditions
- Using other topical treatments
- History of contact dermatitis
Safety Note: AHK-Cu has a favorable safety profile, especially for topical use. The copper content is minimal and unlikely to cause systemic effects.
Monitoring
For Hair Growth
Tracking Progress
- Baseline photographs (consistent lighting/angle)
- Hair counts in defined areas
- Trichoscopy if available
- Patient-reported shedding logs
Timeline Expectations
- 4-6 weeks: Reduced shedding may begin
- 8-12 weeks: Early regrowth signs possible
- 3-6 months: Visible improvement expected
- 12 months: Full effect assessment
When to Adjust
Consider changing approach if:
- No improvement after 6 months
- Significant irritation persists
- Excessive shedding continues
- Scalp condition worsens
Regulatory
Current Status
| Region | Status | |--------|--------| | United States | Cosmetic ingredient; not FDA approved as drug | | WADA | Not prohibited | | Cosmetics | Widely used ingredient | | Availability | Cosmetic products, research suppliers |
Legal Considerations
- Available in cosmetic formulations
- Injectable forms as research chemicals
- Not scheduled or controlled
- Quality varies by source
Comparison: Copper Peptides for Hair
| Feature | AHK-Cu | GHK-Cu | |---------|--------|--------| | Hair Research | Primary focus | Secondary benefit | | Follicle Stimulation | Strong | Moderate | | Wound Healing | Moderate | Strong | | Anti-Aging | Hair/scalp focus | Comprehensive | | Availability | Less common | Widely available | | Cost | Higher | Lower |